Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 07 Dec 2015 New trial record